Influence of age on Salvia divinorum use: results of an Internet survey.
Pearl P Nyi, Emily P Lai, Diana Y Lee, Shannon A Biglete, Gilsky I Torrecer, Ilene B Anderson
Journal of Psychoactive Drugs September 1, 2010 DOI: 10.1080/02791072.2010.10400701 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 219 |
| Population | Salvia divinorum users recruited via social networking websites and recreational salvia group message boards |
| Topics | Salvia divinorum |
| Citations | 16 |
| Key findings | Age at first salvia use was associated with different motivations: younger users favored fun or boredom relief, while older users favored spiritual effects, and older first-time users had higher odds of concurrent marijuana or tobacco use. |
Abstract
An Internet-based survey of Salvia divinorum ("salvia") users was conducted to identify correlates surrounding its use. Salvia-knowledgeable persons were recruited via "social networking Internet websites" (n = 23) where notices were posted on recreational salvia group message boards (n = 69). Data collection included demographics, use circumstances, experiences, and age (current and at first salvia use). A total of 219 surveys were analyzed. Salvia users who were young adults (< or = 21 yrs) at first use favored salvia for fun (OR = 1.94, CI = 1.08-3.49, p = 0.03) or to relieve boredom (OR = 2.06 CI = 1.09-3.91, p = 0.02), while salvia users who were adults (> or = 22 yrs) at first use favored salvia for spiritual effects (OR = 2.63, CI = 1.02-6.75, p = 0.04). Being an adult at first use was associated with higher odds of concurrent marijuana (OR = 2.68, CI = 1.50-4.78, p = 0.0007) or tobacco use (OR = 1.94, CI = 1.05-3.60, p = 0.03). Over half of all respondents reported use reduction or cessation in the past 12 months (114 of 219, 52%), citing dislike of the high (33.3%) or loss of interest in salvia (28.9%). Reports of cessation suggest salvia use may be more attributed to curiosity than continual abuse.
Comparable studies
Other cross-sectional and survey studies on salvia divinorum, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Pattern of use and subjective effects of Salvia divinorum among recreational users. Recreational users of salvia and other psychedelics | 2006 | Cross-sectional survey | n = 32 |
| College student use of Salvia divinorum. College students at a large public university in the southwestern U.S. | 2008 | Cross-sectional survey | n = 1,516 |
| Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Individuals who had used Salvia divinorum and visited related pages of a... | 2010 | Cross-sectional survey | n = 500 |
| Salvia Divinorum Use among a College Student Sample Students at a large public university | 2008 | Survey | |
| Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Noninstitutionalized US residents aged 12 or older | 2011 | Cross-sectional survey analysis | n = 166,453 |
Citations in the library
Cited by 13
- Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology August 1, 2016
- Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biological Psychiatry November 15, 2012
- “Legal Highs” – New Players in the Old Drama Current Drug Abuse Reviews June 1, 2011
- Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects Pharmaceuticals February 3, 2021
- Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Substance Abuse and Rehabilitation April 1, 2011
and 8 more in the library
Cites 5
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. Neuroimage July 1, 2008
- Salvinorin A: from natural product to human therapeutics. Molecular interventions October 1, 2006
- Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology. Planta Medica August 1, 2007
- College student use of Salvia divinorum. Drug and Alcohol Dependence April 1, 2008